- 收听数
- 0
- 性别
- 保密
- 听众数
- 2
- 最后登录
- 2017-12-2
- QQ
- UID
- 9132
- 阅读权限
- 20
- 帖子
- 468
- 精华
- 0
- 在线时间
- 192 小时
- 注册时间
- 2014-4-18
- 科研币
- 3
- 速递币
- 198
- 娱乐币
- 2239
- 文献值
- 0
- 资源值
- 0
- 贡献值
- 0
|
5速递币
题名 | Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial. | 链接 | http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(16)30531-9/fulltext |
|
|